These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The genetic spectrum of familial hypercholesterolemia in the central south region of China. Xiang R; Fan LL; Lin MJ; Li JJ; Shi XY; Jin JY; Liu YX; Chen YQ; Xia K; Zhao SP Atherosclerosis; 2017 Mar; 258():84-88. PubMed ID: 28235710 [TBL] [Abstract][Full Text] [Related]
4. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191 [TBL] [Abstract][Full Text] [Related]
6. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town. Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992 [TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL; Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study. Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225 [TBL] [Abstract][Full Text] [Related]
9. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography. Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355 [TBL] [Abstract][Full Text] [Related]
10. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program. Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475 [TBL] [Abstract][Full Text] [Related]
12. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries. Alhababi D; Zayed H Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195 [TBL] [Abstract][Full Text] [Related]
13. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship. Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735 [TBL] [Abstract][Full Text] [Related]
14. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Miserez AR; Martin FJ; Spirk D Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060 [TBL] [Abstract][Full Text] [Related]
15. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study. Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013 [TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolemia in China half a century: A review of published literature. Peng J; Wu X; Wang S; Zhang S; Wang X; Liu Z; Hong J; Ye P; Lin J Atheroscler Suppl; 2019 Mar; 36():12-18. PubMed ID: 30876527 [TBL] [Abstract][Full Text] [Related]
17. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management. Miname MH; Santos RD Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498 [TBL] [Abstract][Full Text] [Related]
18. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction. Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288 [TBL] [Abstract][Full Text] [Related]
19. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE. Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357 [TBL] [Abstract][Full Text] [Related]